This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CPRX at https://www.zacks.com/ap/CPRX Keywords: Catalyst …
Oct 31 (Reuters) - Catalyst Pharmaceuticals Inc :Catalyst Pharmaceuticals completes enrollment in second Phase 3 trial of Firdapse® in patients with Lambert-Eaton Myasthenic Syndrome.Catalyst Pharmaceuticals Inc - ‍top-line results for …
The stock recorded a trading volume of 2.85 million shares. The Company's shares are trading 5.96% below their 50-day …
WIS23d
The stock recorded a trading volume of 2.85 million shares. The Company's shares are trading 5.96% below their 50-day moving average. Moreover, shares of Allergan, which develops, manufactures, markets, and distributes medical …
The stock recorded a trading volume of 2.85 million shares. The Company's shares are trading 5.96% below their 50-day …
KPLC23d
The best penny stock of March 2017 was Ocera Therapeutics Inc. with a 98.5% return. That crushed broader indexes like the Dow Jones Industrial Average and S&P 500, which gained 0.2% and lost 0.2% last month, respectively. Penny …
For now, the best news for investors may be that Fed members see no obvious cause for concern about the record-high U.S. stock market. The U.S. jobs report from July indicated that unemployment has dipped to its lowest level in 16 …
In a report published Friday, Aegis Capital analyst Raghuram Selvaraju reiterated a Buy rating on Catalyst …
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site …
WIS1mon